Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin.
about
Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin-1The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptorsThe extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblastsHyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activityHeterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridizationDiversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1Bone matrix proteins: isolation and characterization of a novel cell-binding keratan sulfate proteoglycan (osteoadherin) from bovine boneThrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanismsExtracellular matrix macromolecules: potential tools and targets in cancer gene therapyLow thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer.SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cellsThe de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?P2Y12 receptor expression is a critical determinant of functional responsiveness to ATX's MORFO domainDual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healingThe distribution of tenascin-X is distinct and often reciprocal to that of tenascin-CDevelopment of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer.Inferring the transcriptional landscape of bovine skeletal muscle by integrating co-expression networks.Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis.Matricellular proteins in the trabecular meshwork: review and update.Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix moleculesThe extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease.A hierarchy of ECM-mediated signalling regulates tissue-specific gene expressionTenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways.Regulation of interactions between cells and extracellular matrix: a command performance on several stages.SPARC gene expression is repressed in human urothelial cells (UROtsa) exposed to or malignantly transformed by cadmium or arsenite.Thrombospondins as matricellular modulators of cell function.Evaluation of SPARC as a candidate gene of juvenile-onset primary open-angle glaucoma by mutation and copy number analysesCloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expressionPerlecan regulates Oct-1 gene expression in vascular smooth muscle cells.Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2.SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGFMatricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis.Anti-cancer role of SPARC, an inhibitor of adipogenesisActivation of Latent TGF-β1 by Thrombospondin-1 is a Major Component of Wound Repair.SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function.Revisiting the matricellular concept.Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy.Expression of tenascin-C in aseptic loosening of total hip replacement.Matrix metalloproteinase 14 is required for fibrous tissue expansion
P2860
Q24305981-045D690D-1F02-4843-A2D8-7A9AB0786488Q24533305-120FCF3D-5489-420F-A5B4-BC7A686AFFB8Q24563124-2DB2DBE6-6298-496E-91F5-0096FD577875Q24620542-4C83C63C-CB6B-433B-B2F5-DB85E6F61BFAQ24651389-E120EE04-127E-465C-AABF-AA782830CFDFQ24670568-96093128-7C04-4343-86E8-97B949165AA9Q24672489-5D226C76-52DC-4DDD-B212-6635662C9B20Q24683240-6899179C-CC99-4CA7-8A17-59F1FA08BE52Q26823508-1C594CE7-984A-449E-8F04-2FE858753764Q26996081-CA7DA8BB-A26C-4CCB-80BA-AE17634F79E6Q27853327-7CB88132-417A-4AAD-8FA8-27AE03306CBDQ28345301-D79662E8-4DE8-4D00-8CA7-ECCA6484E86AQ28361886-FC229142-2E55-4C5B-9057-CE50F08DD8B0Q28568115-A4C7B45E-E946-475E-98B2-43F6DF47E7B8Q28580473-9BDD8408-C3CA-4280-986F-18F0E59643A4Q28588334-2E4853FE-B9E7-47E1-A306-AED5B82AF06AQ30428429-D28A8AD1-F311-4362-A277-ACD95FFBE349Q33507905-112958C4-1AF0-46C1-9E51-E823711747DEQ33613211-36DFD756-8A9D-4860-9FD9-AA213C386953Q33820048-9C4F2AB4-3F16-4C37-85FA-D98925BF38A9Q33904614-61CE4761-8F9E-4F7C-9BAF-8AFFCA7EAD48Q34022649-85276D45-1B6D-4642-910D-97AA30E4BFD4Q34103381-9BFCA07F-B5D1-4B75-8B57-CB701BFD92B0Q34168346-90C8D892-ED22-4C4D-A9C5-59EDE683767EQ34206366-83F430DA-A4C5-4A53-9354-53512ECFD675Q34208905-80327ED6-DA97-41CD-898E-83BFA27A6BB0Q34221349-957F2B14-0A4A-461D-9880-D1BB924B3C72Q34248616-45F9013A-FD9D-4EC6-A95E-FE5824407C6EQ34441627-FA0F6706-1BF9-4F1D-9A07-ECAD07577C8BQ34670208-65F46758-4F03-4A8A-850B-A359689A5C8EQ34763728-CD7B2F20-678B-4DF4-A7E2-4A149383DBE4Q34979996-C3D736A4-360B-408F-9815-D10E4169F6CCQ35083699-91316286-F22A-4697-B644-9E801E78325BQ35116107-35623477-6C71-4E86-95FE-753E0FF49682Q35147199-66F3C01D-3E17-4A7A-ADFC-61B38E1EA71CQ35176640-3D12447D-7404-498C-B993-FB98F95A1850Q35233858-3A105CC3-25E0-44DB-9A00-AB39DF45D62DQ35320160-3C8805A5-C9E7-495D-9186-AE9405B45455Q35547558-39A8B1B0-C27A-4985-BA59-4761CC40C3E1Q35781999-BD8AEB7C-D74C-4DE6-BBFD-82CB4C153BCE
P2860
Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Extracellular proteins that mo ...... tenascin, and thrombospondin.
@ast
Extracellular proteins that mo ...... tenascin, and thrombospondin.
@en
type
label
Extracellular proteins that mo ...... tenascin, and thrombospondin.
@ast
Extracellular proteins that mo ...... tenascin, and thrombospondin.
@en
prefLabel
Extracellular proteins that mo ...... tenascin, and thrombospondin.
@ast
Extracellular proteins that mo ...... tenascin, and thrombospondin.
@en
P1476
Extracellular proteins that mo ...... tenascin, and thrombospondin.
@en
P2093
P304
14831-14834
P407
P577
1991-08-01T00:00:00Z